نتایج جستجو برای: fda

تعداد نتایج: 16323  

Journal: :Biomedicine Hub 2017

Journal: :Journal of Cardiovascular Translational Research 2010

2001
Toru Hirayama

The energy-momentum tensor of the Liénard-Wiechert field is split into bound and emitted parts in the Rindler frame, by generalizing the reasoning of Teitelboim applied in the inertial frame [see C. Teitelboim, Phys. Rev. D1 (1970), 1572]. Our analysis proceeds by invoking the concept of “energy” defined with respect to the Killing vector field attached to the frame. We obtain the radiation for...

Journal: :AANA journal 1996
R Manley J D Cuddeford

In 1978, the Food and Drug Administration (FDA), developed a generic anesthesia equipment preuse checklist. The checklist was first released by the FDA in August 1986 and endorsed by the American Association of Nurse Anesthetists on October 18, 1986. The FDA checklist was revised in 1992 to improve the abilities of anesthesia providers to detect machine faults. In the present study, the investi...

1998
Jonathan M. Kagan

s of the NIH-FDA Conference “Biomarkers and Surrogate Endpoints: Advancing Clinical Research and Applications” Abstracts of the NIH-FDA Conference 188s of the NIH-FDA Conference 188

Journal: :Chemical communications 2014
Jordi Aguilera-Sigalat Darren Bradshaw

We report for the first time the pH-dependent fluorescence of UiO-66-NH2 across the wide range from 1 to 9. By application of a post-synthetic modification (PSM) diazotisation strategy, we synthesized a new material, UiO-66-N=N-ind, which shows increased chemical stability and enhanced sensing up to pH 12.

Journal: :Clinical chemistry 2013
Mitchell G Scott Edward R Ashwood Thomas M Annesley Debra G B Leonard Michael C Burgess

In 2010 the US Food and Drug Administration (FDA) stated that it would issue guidance on its oversight of laboratory-developed tests (LDTs), and in July of that year the FDA held a public meeting to receive feedback on a risk-based application of LDT oversight (http:// www.fda.gov/MedicalDevices/NewsEvents/Workshops Conferences/ucm212830.htm). The FDA acknowledged that LDTs have been in existen...

2008
Armando Oliva

Bioinformatics is the design and development of computer-based technology to support the life sciences (1). At FDA, bioinformatics means the design, development, and use of modern computer systems to efficiently and effectively manage the regulatory product information supply chain, along which medical product information travels among the many relevant organizations (eg, study data travel from...

Journal: :Journal of Machine Learning Research 2012
Fei Yan Josef Kittler Krystian Mikolajczyk Muhammad Atif Tahir

Sparsity-inducing multiple kernel Fisher discriminant analysis (MK-FDA) has been studied in the literature. Building on recent advances in non-sparse multiple kernel learning (MKL), we propose a non-sparse version of MK-FDA, which imposes a general lp norm regularisation on the kernel weights. We formulate the associated optimisation problem as a semi-infinite program (SIP), and adapt an iterat...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید